Home Biosimilar Antibodies Proteases Tyrosinase Flanvotumab (Anti-TRP1 / TYRP1)
For research use only. Not for use in humans.

Flanvotumab (Anti-TRP1 / TYRP1)

Synonyms: IMC-20D7S

Flanvotumab (Anti-TRP1 / TYRP1) is a monoclonal antibody directed against the melanosomal membrane protein gp75 (or Tyrosinase-Related Protein 1 (TRP1)) with potential immunostimulatory and antineoplastic activities. MW: 145.5 kD.

Flanvotumab (Anti-TRP1 / TYRP1)

Quality Control

  • Cited in Nature Medicine for its top-tier quality
  • SDS
  • Datasheet

Specificity

Name Citation tyrosinase monophenolase diphenolase Others
Deoxyarbutin 0
Kojic acid dipalmitate 0
Calcium 2-oxoglutarate 0
Kojic acid 1
Hexylresorcinol 0
Arbutin 3
Oxyresveratrol 1 DPPH
Aloin (Barbaloin) 9
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Flanvotumab (Anti-TRP1 / TYRP1) is a monoclonal antibody directed against the melanosomal membrane protein gp75 (or Tyrosinase-Related Protein 1 (TRP1)) with potential immunostimulatory and antineoplastic activities. MW: 145.5 kD.

Product Details

CAS No. 1188277-05-5
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.